Long-term percutaneous cardiopulmonary support using a newly developed heparin-binding oxygenator successfully treated 2 patients with acute severe myocarditis and cardiogenic shock.
Case Report (n=2)
A newly developed heparin-binding oxygenator and circuits for PCPS is feasible for prolonged extracorporeal circulation in patients with cardiogenic shock from acute severe myocarditis.
The feasibility of using the heparin-bound percutaneous cardiopulmonary support system (PCPS) for prolonged extracorporeal circulation in patients with acute severe myocarditis is demonstrated. The case histories of 2 patients with cardiogenic shock caused by acute myocarditis are presented; both were successfully treated with long-term PCPS using a newly developed heparin-binding oxygenator and circuits without changing the oxygenator. The courses of both patients remain uneventful more than 12 months after discharge. We also discuss the clinical aspects of using heparin-bound PCPS in patients with acute severe myocarditis.
Yasu et al. (Wed,) conducted a case report in Acute severe myocarditis with cardiogenic shock (n=2). Heparin-bound percutaneous cardiopulmonary support system (PCPS) was evaluated on Successful treatment and clinical course. Long-term percutaneous cardiopulmonary support using a newly developed heparin-binding oxygenator successfully treated 2 patients with acute severe myocarditis and cardiogenic shock.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: